§ BIOTECHNOLOGY
USD · Biotechnology

PGEN

PRECIGEN INC
USDSector · BiotechnologyBeta · 0.99
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
126 increased/new, 52 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B70.73EPS (TTM)-0.52
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Patient Capital Management, LLC17.8M2.5%−5%
BlackRock, Inc.15.2M0.0%+1%
State Street10.9M0.0%+1%
VANGUARD CAPITAL MANAGEMENT LLC7.1Mn/an/a
Diametric Capital, LP6.8M6.8%+77%
Point726.6M0.0%−52%
◇ AC INTELLIGENCE

Top institutional owners for PGEN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER58.9% · 0 holders
OTHER25.1% · 145 holders
DEALER / BANK6.6% · 19 holders
PASSIVE / INDEX6.2% · 9 holders
QUALITY / COMPOUNDER1.8% · 11 holders
TACTICAL / MACRO0.9% · 3 holders
INCOME / DEFENSIVE0.2% · 12 holders
SYSTEMATIC / QUANT0.2% · 5 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for PGEN in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention PGEN yet.